Protalix Biotherapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.2M | 3.3M | 1.26 |
| 2023-09-30 | $5.3M | 3.2M | 1.66 |
| 2023-06-30 | $5.3M | 2.6M | 2.00 |
| 2023-03-31 | $244k | 116k | 2.10 |
| 2022-12-31 | $140k | 102k | 1.37 |
| 2022-06-30 | $110k | 102k | 1.08 |
| 2021-06-30 | $236k | 123k | 1.93 |
| 2021-03-31 | $6.0k | 1.4k | 4.38 |
| 2020-09-30 | $24k | 6.3k | 3.82 |